CNS Depressants
Includes alcohol & a
wide variety of drugs used as sedatives, sleeping pills, anti-anxiety
tranquilizers, anesthetics, and anti-convulsants.
Dose-Dependent CNS
Depression
u Depending on dose, you may
experience
l calming, relief from
stress/anxiety
l disinhibition, intoxication
l sedation
l sleep
l anesthesia
l coma
l death
General CNS Depressants
u Dose-dependent CNS
depression
u Additive or, more often,
synergistic interaction with other depressants
u Cross-tolerance and
cross-dependence
u Hyperexcitability rebound
afterwards
u Low doses may appear
“stimulating” because of depression of inhibitions
u Withdrawal can be dangerous
Barbiturates
Classic non-selective CNS sedative/hypnotics or
“downers” that dominated the market 1903-1960
Barbiturate
History
u Developed in the 1860’s by
Adolph Bayer
u 1st marketed in 1903; over
50 developed
u Leading depressant group for
~50 years
u Only ~12 varieties currently
used
u Superseded by more selective
drugs
Characteristics of
Barbiturates
u Barbs differ in length of
action (ultrashort (mins.),
short <4 hr, intermediate 4-6 hr , long >6 hr) Affect brainstem reticular
formation
u General depressant effects
almost indistinguishable from those of alcohol
u Depressant action due to increasing
the inhibitory effects of GABA and triggering inhibition even in the
absence of GABA
u Higher doses affect other
transmitters.
GABA Receptor
Some Well-Known
Barbs
u sodium thiopental
(Pentothal)(U)
u secobarbital (Seconal)(S)
u pentobarbital (Nembutal)(S)
u amobarbital (Amytal)(I)
u phenobarbital (Luminal)(L)
u These drugs were widely used
as sedative/hypnotics, anesthetics, anticonvulsants
Problems With
Barbs
u Nonselective effect even at
low doses
u Low safety margin; easy to
overdose & cause lethal depression of breathing; used in suicides
u Dangerous interaction with
other depressants
u Rapid development of
tolerance
u Risk of significant
dependence
u Possible life-threatening
withdrawal
u Decreased REM; morning
grogginess
u Withdrawal rebound in
insomnia & anxiety
u Memory and cognition impaired (like alcohol)
u 2-3 X increase in birth
defects
Barbiturate
Withdrawal
u begins with growing anxiety,
agitation, the shakes, GI upset & bodily arousal
u severe withdrawal includes
delirium, seizures, uncontrolled HR & possible death, even with medical
supervision
u This dose-dependent
withdrawal, is very similar to alcohol withdrawal & is characterized by
hyper-excitability of body and brain.
Barb Use in H.S.
Reasonable Use of
Barbs
u To control seizures (only
good use of oral barbs)
u As an intravenous anesthetic
u Sedation in emergencies or
in therapy
u To reduce brain activity,
blood flow & release of glutamate after severe head injury
u In assisted suicides
u Barbs should not be
used as anxiolytics or hypnotics
“Non-Barbiturate”
Sedative-Hypnotics
u Examples:
l methaqualone (Quaalude)
l meprobamate (Miltown)
u Promoted as an improvement
but turned out not to be
Benzodiazepines
u “Minor Tranquilizers” or
“Anxiolytics”
u More selective CNS
Depressants (doses that relieve anxiety do not produce as much general
depression as barbs)
u 15 different benzos
currently available
u Benzodiazepine binding site
on GABA receptor
Long Acting
Benzodiazepines
u *Valium - diazepam
u *Librium - chlordiazepoxide
u Dalmane – flurazepam
u Paxipam - halazepam
u Centrax - prazepam
u Tranxene - chlorazepate
u Provide sustained effects
when needed (anticonvulsant; muscle relaxant; alcohol withdrawal; for those
with both insomnia & daytime anxiety)
u Avoided in the elderly
Short and
Intermediate Acting Benzodiazepines
u *Xanax - alprazolam
u Halcion - triazolam
u Versed (midazolam)
u Serax – oxazepam
u Ativan - lorazepam
u Klonopin - clonazepam
u Restoril - temazepam
u Pro-Som - estazolam
Treatment of
Anxiety Disorders
u Panic Disorder – Xanax &
Klonopin are FDA approved, others used “off-label”
u Effective within 1-2 weeks;
results in up to 75% being free of attacks
u No tolerance to therapeutic
effect
u Recurrent panic attacks upon
withdrawal (25-50%) so long gradual over several months recommended
u Side effects:
sedation/drowsiness (38-75%);
memory impairment in up to 15%
Generalized
Anxiety Disorder
u All benzos equally effective
– produce moderate-marked improvement in 66%
u Effective in 1-2 weeks; ~
50% smaller dose needed than panic disorder; no tolerance to this effect over
years
u Especially good for somatic
symptoms
Social Anxiety
Disorder
u Xanax & Klonopin
demonstrated to be effective in ~ 78%
u BUT: this patient group
often has comorbid alcohol/substance
abuse which complicates the use of bezos
*Rohypnol - the
“date-rape drug”
u “Roofies” are a potent
benzodiazepine (flunitrazepam) not
marketed in the US but similar to Halcion. Actually any combination of alcohol
+ sufficient benzo could produce similar effects.
Benzodiazepine
Benefits
u more selective anti-anxiety
action, lower levels of depressant side effects
u wide safety margin (high LD)
as long as other depressants aren’t used
u antagonist *flumazenil (Romazicon) available for overdose
situations
u less tolerance and
dependence
u less dangerous withdrawal
u sleep is more normal than
with other depressants
Problems With
Benzodiazepines
u dependency still possible
u may be rebound insomnia
&anxiety when stopped
u over-response in elderly
common; idiosyncratic responses possible
u may impair memory
u may cause birth defects
u driving problems common
u don’t solve original problem
in most cases; may be overprescribed
The Search for
Even More Selective Drugs
u more “selective”drugs affect
only a sub-group of receptors
u Selective 5HT-1A agonist
buspirone (Buspar) (not a CNS
depressant)
l Antianxiety action (delayed)
without other depressant effects
u Selective GABA-A1 agonists
zolpidem (Ambien) & zaleplon (Sonata)
l Hypnotic effects without
antianxiety, anticonvulsant or muscle relaxing effects
Alternatives to
Depressants
u Antihistamines
l diphenhydramine (Benedryl)
l hydroxyzine (Atarax,
Visteril)
l promethazine (Phenergan)
u Beta-blockers
l propranolol (Inderal)
u Antidepressants
l amitriptyline (Elavil) &
doxepin (Sinequan) used for sleep
l SSRIS now used for most
anxiety disorders